A Study of Insulin Glargine (LY2963016) in Healthy Chinese Participants
Status:
Completed
Trial end date:
2019-11-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare a study drug known as Insulin glargine with Lantus in
healthy Chinese participants. Blood samples will be taken to compare how the body handles the
drugs and how they affect blood sugar levels. Side effects and tolerability will be
documented. The study will last at least 18 days, not including screening. Screening is
required within 4 weeks prior to the start of the study.